Patients with hematologic malignancies and solid tumors may be referred to the Center for Gene and Cellular Immunotherapy at Washington University School of Medicine for evaluation to receive approved standard of care immunotherapies or to be considered for enrollment in a clinical trial.
For all inquiries: 314-273-2355 or 833-273-CELL (2355)
